Overview

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

Status:
Completed

Trial end date:
2010-07-15

Target enrollment:

Participant gender:

Summary

Observe whether the administration of caffeine prior to regadenoson will affect the interpretation of test results in subjects with coronary artery disease (CAD) undergoing SPECT MPI

Phase:

Phase 3

Details

Lead Sponsor:

Astellas Pharma Inc

Treatments:

Caffeine
Regadenoson